January 14th 2021
Weijing Sun, MD, FACP, discusses the design of the KEYNOTE-062 trial in advanced gastric/gastroesophageal junction cancer.
Jordan D. Berlin, MD, discusses unmet needs in pancreatic cancer.
January 13th 2021
Sikander Ailawadhi, MD, discusses the emergence of T-cell engagers in multiple myeloma.
Phuong L. Mai, MD, discusses barriers of genetic testing in colorectal cancer.
Yi Lin, MD, PhD, discusses CAR T-cell therapy–related toxicities in multiple myeloma.
Ryan Sullivan, MD, discusses treatment sequencing with targeted therapy and immunotherapy in melanoma.
Yelena Y. Janjigian, MD, discusses the importance of routine HER2 testing in gastric/gastroesophageal cancer.
Rafael Fonseca, MD, discusses the emergence of minimal residual disease in multiple myeloma.
Michael Schweizer, MD, discusses the results of the HERO trial in prostate cancer.
Daniel J. DeAngelo, MD, PhD, discusses the utility of moxetumomab pasudotox-tdfk in hairy cell leukemia.
End of data